Exactly, there would be only a short delay from Linda's late September deadline for Topline, for which the ihubers have been hysterical since last Thursday.

And the so self-claimed longs;

The skittish, the knee-jerking, and the lost shares;

The greedy, naked short wolfpack commissioned corrupted no-guts MM with measly volumes showing weak hands;

Let alone the vast armies of constant flip flopers who at end always lose more than gain.

All will lead to a much much higher initial and lasting upward price movement

The same story will go on and on.

Who call them stupid. you are talking about specific cases and I am talking about general trend. That's a huge difference.

If you want to talk about specific cases, I bet some people also buy high and sell low.

And that small number of cases regardless is useless in our discussion.

The point being MMs manipulation which can only be successful because there always being stupid investors, skittish, knee-jerking, and because of the selfishness of constant flip floppers.

Be noted I am one of those investors who have bought their most shares at teens, twenties, and thirties, and have since averaged up.

Simply, nothing has changed despite daily mood changes in ihub regarding the success of bringing DCVax platform into market, and I believe the company has been working hard to maximize the potential of the platform, and it's understandable the process may not go as smoothly as most expected.

To that end, the company should not act like a baby sitter.

[Guess this is my last post allowed, so bye for today]

Have you noticed the date of my post? The measly volumes in a down day tell you a lot about the health of the recent days transactions -- transit, temporary, and manipulated. It cries out BUY, BUY, AND BUY!

MMs can succeed in bringing the price down some because there are always too many stupid investors, skittish, some genuine duo to lack of experience, or out of nature, but more are pathetic thinking they can constantly flip flop, selfish and at end always lose more.

I feel smart because of these skittish kids, and the work of the naked short wolfpack.

I know I can make much more money because of them, hence averaging up.

Thanks for giving me more cheap shares. Just bought two batches around 0.7

Some people are just pure stupid -- the blinded data already show DCVax-L will be approved, but with improved, better data to be expected from unblinding, the approval process may be speedier and the market success may be grenadier.

Have $50k more to put in work today!

Bottom line:

If the trial fails, we would have been notified by now;

Either the delay is related to regulatory process/discussion or not, or behind the scene bargaining of big P or Ps with the company, it will pan out in due time;

DI is out of loop, give the guy a break;

It more and more looks like some knee jerking longs will lose out big, along with the unfortunate and pathetic naked short wolfpack during the process.

Just relax, observing, or add some more shares here and there when the price is depressed, or simply go take a break.

Spartex, it's Chinese, and Chinese often say that with optimism.

[img][/img] It reads hao shi do mo



Nothing Good Comes Easily!

Even with FDA's involvement in this stage, all the announcment/PRs will fall onto company's shoulder. FDA as usual works behind the scene.

With that said, it's still likely the next update we will see is Topline data announcement despite most think it is delayed.

In my decades of biotech investment, I have never ever heard statisticians of a pivotal Phase 3 trial need several weeks to analyze locked data, and never ever heard the underlined company after receiving report from statisticians, needs several weeks to consult with their experts before the company is ready for Topline data announcement.

Nor have I ever heard a company needs one or two months to have a hard data lock when every set of data has been collected.

It's usually a two months to three months time from a company reaches its designed endpoint counts, either progression free survival or overall survival, and you name it, to topline announcement, and if the trial fails, the announcement comes much sooner.

I once lost about $200,000 in two days when I bought low and gambled the underlined company, which I didn't believe it had any chance to succeed, and the company just announced it reached endpoint counts, and estimated it would need 2-3 months to get topline data ready a month earlier. The share price had been dropped like a free falling rock, and I thought I was safe for a quick profit selling into the anticipated rebound of share price well before the two month deadline. Well only two days after I bought, in the 45th days, the company suddenly announced it failed in the trial.

Now back to nwbo, it is of course a totally different story. Because its strong science foundation, positive blinded data backing and stalled SOC, most investors believe its DCVax-L trial for GBM patients will be a success, the difference being how success it will be.

Despite all the above, why is the company so conservative and even out-of-bounds in its timeline estimation to get topline data, and it may have not yet had data locked today?

The only conclusion I can come with is more or less the involvement of the government authorities such as FDA. In normal cases, FDA won't participate during this stage; if the trial is a failure, FDA won't spend a second to get involved, particularly when the pandemic has exhausted its time.

In addition, there is also a suggestion by Dave Innes in a recent conversation with one poster about government involvement, and the yet-to-finalized FDA guideline which seems tailored in some way to our DCVax-L trial.

Well, it seems there is a reason of the out-of-bounds timeline and continued confusion about it!

Marzan you are absolutely right that companies should not irk the FDA in any way and form because FDA is vindictive. I guess there is no company which has done a better job than nwbo under Linda Powers, particularly considering the suspected malicious act involving FDA in the partial halt for screening new patients years ago.

Exactly because of that, the relationship between nwbo and FDA has been in the mend ever since, culminating on the lift of the partial halt, which took place years ago later.

Then the suspected involvement of nwbo in the new draft guidance of FDA.

Perhaps FDA has been actually closer than one would suspect in guiding the concluding of our Ph3 DCVax-L trial, sort of as its own experiment/test for the new guidance; perhaps the finalization of its new guidance is pending the conclusion of Ph3 DCVax-L trial.

Anyhow, if FDA's involvement in the Ph3 DCVax-L trial in this stage is true, that would be really interesting.

In addition, I guess maybe FDA has had all the documents necessary for an approval (condition or not) except the final trial results, and of course a formal application.

Thanks for pointing out that, but the point of my post regarding suggested government involvement and possible consequence, not only topline data announcement but also maybe conditional approval at the same time or shortly after topline data announcement still stands excluding Les's last year TV show (or any of Les's TV show ever existing).

Why involve the government in this stage of DL and topline preparation? Perhaps, IDH data, etc, is requested by FDA, and the company has been sitting on the backbench for quite some time.

When everything is checked and ready. We will be notified.

Again, maybe not just DL, Topline data, there is more to come!

Amazing development is unfolding right before our eyes if RuleofK's conversation with DI regarding DI's suggestion of government involvement in this stage of DL and Lykiri provided bigbiz show dated today, 26 September which, unlike all the previous shows which predicts the timing of DL and Topline data, in today's Les' interview with Bigbiz show, there is no mentioning of either DL or Topline data.

Coupled these with two shift overtime working at Sawston to make available of sizable manufacturing capacity by October, a very clear picture emerges:

When Topline data is announced either as scheduled by the end of September or in couple of weeks, it may accompany a conditional FDA approval as well, if FDA has involved in this process, which can readily explain why the confusion and why the delay in data lock, etc. I guess FDA is unblinded, and LL is semi-unblinded, and as of today the company is still blinded. And FDA is the one who gives instruction.

That is what has come to my mind at the time being. BTW, Les' excitement in today's show about the huge potential of DCVax platform is genuine, very much unlike his makeup.

Wow I am happy I have added to my position last week, and intended to add more in the coming weeks.

This is my last post today. GLTA!

“If it's bitter at the start, then it's sweeter in the end.”

? Madonna

It seems most posters in this board are traders, flip flopers unfortunately judged by their posts in this board. The company has been very consistent in timeline, i.e., ambiguity for a reason.

Some have got the words via phone or email indicating the company will announce data lock, of course the hard data lock, aka the final data lock, while in prerecorded presentation and other information strongly suggest topline data in later the month of September.

Even the "later in the month of September" itself in a complete sentence is ambiguity in hindsight.

The point has always been and still is today that the company, though confident in positive outcome of the trial, has only this chance to get it right to show its worth, and it cannot afford to mess it up. And if the company has two winning cards, it should not rash to announce one card while messed up with the other.

From the repeated goal post moving in the past to today's intentional ambiguity in the timing of topline data, the company has been very transparent actually and consistent. So it is a bit of worrisome that so many investors have been surprised by Les's unfortunate prerecorded bar show, let alone complaining and screaming afterwards. If there is one thing the company needs to change its behavior, that would be to ban Les from ever appearing in such unfortunate show. Grow up and prepare for big-time prime TV show instead!

The ultimate goals of the company and ours are the same: to first successfully conclude the Phase 3 DCVax-L trial for GMB with at least good enough results for regulatory approvals in four countries, and second to bring the then concept-approved DCVax platform into full capacity to treat all operable and inoperable solid tumors.

Then how come the repeated overreaction because of too many flippant flip flops. During such periods, unfortunately some have fell for the prey of the greedy wall street/stock market. After all, what really is the significant difference between a few pennies/dimes' advantage in share price and a share price which will be $5 or more in a short term from within several weeks to a month or two if you would?

Next time, calm down boys and girls! No shaken up, take advantage if such situation repeats to add in your positions if you want more in your portfolio. Let the naked short wolfpack and other agitators pay the costly price in the end.

Remember the company needs a wiggle room, which is for the good of all us investors, and most importantly for the future patients.

It is those who play with fire will get burned.

God blesses topline data tonight or Monday morning. That would be real fun!

I know it's unlikely after Les' clown show, but it's never impossible with God.

Bought three batches of shares today!

FOR PEOPLE WHO DON'T THINK LINDA HAS A REAL PEEK OF DATA AND IS PRETTY CONFIDENCE IN BRINGING THIS PLATFORM TO PATIENTS AS MANY AS POSSIBLE, THEN IT'S NO CURE FOR YOU. SO WHY DELAY, IT'S PERFECTION!

BUY AS MANY AS YOU CAN AFFORD. ITS NO BRAINER

By noon's time we will clear all the traders and some opportunistic shorts, then that's the time for "an update."

BTW, where are those big guys who are holding 100 million shares/warrant?

Can they drop 100k cash to buy the dip? Or they are the guys making the dip?

[Just confirm another batch of shares bought around 0.73]

[A little more than 2 million share transaction made this 5 pennies of drop. pathetic]

Aimed at 0.77 yesterday, and got filled today around 0.74

Like volatility because I have made available of funds. Let's go Linda.

Never know if update = topline? If not, can wait for a little while longer

Make money work more profitably perhaps

this trend of past several days definitely kill traders

Next is the naked short wolfpack, which is always in Linda's mind, let alone Les's

I don't think whether primary endpoint PFS meets or not is important enough to scare people away from taking/adding positions if OS shows significant improvement via HR, and landmark 2-, 3-, 4- and 5-years survivals compared to placebo, later vaccined patients, etc

Yes the short may have an hour of confusion and deception impacting stock price in a significant way. It will be transient.

We have well passed PFS days when it was meaningful. Of course I believe we will meet PFS target in a statistically significant way.

Get dry powder ready!

No worry this stock is a retail stock despite somebody claims to have the control of 100 million shares/warrants, or at least those self-claimed long hedges have not done their parts yet to maintain/protect their positions.

I have been buying more again ever since the price had dropped to low 0.80s.

Today I get a bit greedier and my buy order has yet to be filled around 0.77, missed the first wave down to 0.76. May raise my bid later depend on situation.

the beauty of this stock is that we have had no big fish onboard yet. Bigger or the guy claimed he would have to file 13f in the future when warrants convert are just like most posters in this board, better at lip work

so we will be rise exceptionally huge when topline data is released because at that time we will truly have some bid fish swimming in nwbo pond/ocean

until then, happy to add

Look at the pathetic volume. you are lawyer you should be able to comprehend.

These jerks should pass big volume trading to each other to make it real

Grade F for their job.

I could be only quickly enough to catch 9k shares at 0.833, then the price went up.

too old and not enough time to watch every dirty move

[Sorry not directly in reply to you bio]

Shout from the rooftops: Topline data any day within 6 trading days!

In Lindas we can believe!

Because of the science, the data we have known, and ironically the market.

Yes the market has awaken. Dynamic has changed. Naked short wolfpack has broken up among themselves!

Gap up tomorrow. Yes you right I am talking about nwbo.

[some people never change until it's too late]

I know it's premature to express my deep appreciation to Linda Powers and her brilliant leadership for guiding this trial into fruition as we are awaiting topline data announcement anytime now ("later in the month of September")

God forgives and blesses I said it now!

If it is not for the publication of the interim blinded data in Journal of Translational Medicine in 2018, and the subsequent updates, I have not been so assured and ease in continually adding shares to my already large position whenever share prices were weakened. And the fact is now I have been able to average up!

Nobody is and should be happy for having gone through those dark days when the company has had to go through repeated deteriorating dilutions as if there would have been no end of it.

We now know how extremely hard for Linda to lengthen the trial not by months but years while maintaining the integrity of the trial because it's important and vital to bring the effect of immuno-oncology (IO) agents such as DCVax-L into full strength in treating cancer patients, which requires years of following up.

In effect, most other small biotech companies with phase 3 trials for GBM have failed due to a variety of reasons. For one important reason, I think it's because their leaders' lack of steel will, long-term vision and vulnerabilities to the market force which has been always hostile to promising small biotech companies. It seems we are an exception, a pleasant exception because we have an exceptional leader; all other big pharms have also failed in their trials of various agents in treating GBM patients despite very resourceful because their treatments are either unsafe and/or ineffective. We are only one standing!

Thanks to Linda we have come a long way and only a few yards away from reaching our first milestone goal: prove both the safety and efficacy of DCVax-L for GBM patients.

Again God forgives and blesses!

Hi marzan, I think this time the AF + hedge fund combo won't work simply because nwbo has had so many investors who are really committed because of science for which AF and friends don't understand.

Regardless nwbo will have a cult following by a very large number of retail investors plus perhaps dozens of small long hedge funds.

In my decades of biotech investment, I have never ever come to know so many retain investors who have been unbelievably knowledgeable on how DCVax works, its MOA, and what's the status of GBM clinical trials and treatments, and the current best cares/standard cares, etc.

These investors will not be easily shaken off and let go their collectively huge numbers of shares in case disinformation/fake news/deceptive analysis is released by any of the naked short wolfpack.

In addition, AF's appeal as frontman for short hedges has been severely damaged ever since he left the street due to several high profile bad calls and aftermath consequences. If ever naked short hedges want to conspire with him in the future, the effect will be temporary in my opinion.

We are educated with knowledge of DCVax. Next will be the mainstream media after topline data are released.

Actually the share price movement since around 1 September has been a testament that the wolfpack has been broken, and they will run for the hills. I like to see a stampede aka squeeze, not only for my profit but most importantly for GBM patients!

Definitely not small fish like you and me. Use your imagination. Most who have done their DDs think DCVax-L Phase 3 trial for GBM will be successful, meaning FDA approvable, but there are some who think otherwise.

Some of those who think otherwise have been much more resourceful and bold, let alone they may have other agenda other than making money.

The trading history and pattern of deteriorating endless dilutions in the past tell the story; AF, the never ending forces who have turned good news into bad; the few proliferate posters who have never ever said a single word good about the company; our own SV Les who despite unlikable by many who have talked with him has repeatedly claimed hundred of millions of naked short shares; and CDEL if you watch trading everyday which has been in the ask with lower price at any opportunist times with 100 share lots when volumes are low and recently 1000 share lots when volumes increase.

Yes anybody's selling order may be directed to CDEL or any other MMs, but its strange lots and never ending lowest ask price, meticulously and painstakingly opportunistic timing tell a story: you would think CDEL likes to lose money, right? It has definitely lost a lot of money when share price has been appreciated in recent months from low 20 cents to today's 80 cents, and CEDL has been always at the lowest ask. Even a rock know CEDL has been losing money for fun, and yes CEDL never adjusts. Does that tell a story of naked shorting and stubbornness.

No point to argue, we will know soon enough when Topline data is announced.

Most people don't believe, but it's actually very prevalent for hedge funds to have significant naked short positions in most small biotech companies in the face of a binary event regardless what the share prices are.

That's your lawyerly statement? I bought today around 0.86, and then 0.84 because as I said a few days ago: anything below $1 is no brainer.

[Have averaged up almost daily!]

[Notice when we are up volumes are up and when we are down volumes are down. CDEL is just a pathetic MM, constantly putting out 1k lots at lower price at the ask]

Definitely the buying pressure is here and strong so if larger buyers are not materialized today, they will be tomorrow risking aftermath of topline data announcement.

I am expecting to see some familiar names missing the days ahead. Nothing wrong with some profit taking, but some turning into a sour grape is pathetic.

Average up!

Gap up late this afternoon! Some old timers have been replaced by new comers, which has always been the case in high-profile stock appreciation history.

Get ready for gaping up!

That shorted number is a peanut. the wonder is the naked shorted shares which is believed to be around 200 million large. Though disputable, we will see!

marzan I believe we don't need to go through the usual Nasdaq listing process/procedures as we are former Nasdaq listed company and it seems very clear Linda has been preparing for uplisting/back to Nasdaq for some time. The recent up-to-date filing is evidence.

After positive topline data which will be announced within two weeks, there will be no obstacle to go back to Nasdaq. For instance, no investors will complain to have a reverse slit of stock 1 for 4 or 1 for 10 to make the stock price to $4 or $10 per piece if the stock price is $1.

I personally think if the results are positive enough, the stock price will be well above 1 and may readily reach $4 and $5 in a short time thanks to the current general crazy market environment and widespread awareness of humans own immunization system which can do wonder.

GLTY and GLTA longs.

[With short squeeze which we are definitely having one, big or small, the share price may easily go above $10 in a few days]

Yesterday's filing (D form) may suggest it has something to do with acquisition, partnership, etc. Because of the date mentioned, ie, late August, people are quick in making a conclusion that it is related to Flaskworks acquisition. The fact is nobody knows for sure at this time, and there is reason why the filing doesn't specify.

Now today's 8-K/A which seems to show merely a fiduciary responsibility of CEO Linda to the investors of the company in regards to one resolution of the early shareholder meeting on compensation as if the company has been always up to date with SEC and its shareholders.

So what gives. Regardless, we will find out soon, and most important thing is there are only 10 days left for trading in September.

Topline data will be announced "later the month of September" literally means any day of the remaining days in September.

Com'on flipper44.

Is this Linda's statement clearer than would be expected:"...later this month of September, we will be expecting to unblind, unvell, and announce, finally, the results of our 13-year long Phase 3 trial of DCVAX for Glioblastoma brain cancer."

Twelve trading days left in September. If you want 100% correct, you can choose the 30th of September.

Nobody can outsmart the market, which Linda knows and we all know. In the things regarding NWBO, admitted or not we have to deal with the naked short wolfpack, let alone a vast army of traders who think they have ultimate mastered the market.

Shorts have to pay back; "smart" traders have to pay back, and yes good luck to patients.

Nothing wrong with me flipper44. I am well and sound. Just interested to point out some subtle observation if I am not that busy.

this is the last post of mine. GLTA

[Can I say it again, we are just experiencing a mini-gap up today. More to come]

Today we are in the stage of a mini-gap up warm up. Still far away to reach $2 for those self-claimed "leveled" investors to load up all the way to $10.

Well I am sorry I didn't buy more enough to help you guys to reach that goal as quickly as possible so you guys have to continue your "leveled" opinion in this board a bit longer. I do appreciate your honesty though.

Finally, after a repeated endless 1k shares offer at ask by CDEL at 0.599, the ask was forced to move up. CEDL may come up with a price for its next endless 1k shares offer in order to damp enthusiasm, but it's okay in a warming up stage, we can just move step by step with tons of patience.

For folks who think we have a functional market economy governed by rules of law, they are at the front of the corporation ladder, like the guy blue bashing something, never in the position of executive ranks (not a mom and pop business of course).

Meaning, if you want a big piece of a penny stock, there is no obstacle for any major Wall Street institution to have it, such as the $5 limit, OTC limit, etc, but all these are to fool retail investors, or the masses. SEC will be a guarantor!

Be prepared.

Really. No flip flop. I did not see you in the land of 10s and 20s cents. It doesn't matter anyhow and shorts are killing themselves.

No need for us who have average up. We compete with shorts in the way down and up regardless.

Positive topline within two weeks

Gap up tomorrow!

In a lawyer's mind [you are one of them, aren't you?]:

"...are expected to be unblinded and announced later this month."

Meaning:

...are expected to be unblinded and announced later this month [to the general public]

See the difference?

Bought 50k more shares today at around 0.555. Yes I am prepared to short NVCR when the pig is fatty enough, meaning when NWBO substantially rises in price again. Then start to short, depending on situation, may short more

In the meantime, at a price below $1, NWBO is a buy!

Done my posts today. I am going to take a break.

Good weekend NWBO longs

The manipolators MM/Naked wolfpack has been working hard to make a trend of downward price movement in recent days so some smart ones think they could sell now and buy later for cheaper shares while other smart ones would be waiting on the sideline thinking the bottom has not been reached.

While doing that, MM/Naked wolfpack are pumping up NVCR for short when DCVax-L trial results are published

Greedy, a purely and totally greedy bunch! There are only 12 trading days left for September!

Each individual investors have their own situations and conditions. For me there is no brainer to average up until $1 - this is my view at the time being.

And which is based on not super results but a controversial one, ie, longs believe it will be approved while shorts (if there are genuine) think it will not garner approval.

But I believe the trial results will be positive enough to get all four countries approval.

Care to point me to where I have said that? I did say that when price fell under $1, then $0.5, let alone in teens.

In all these price ranges, I have not said it but bought increasingly more shares. Now I am in black, up six figure paper profit at least.

Still committed for a long term gain with the vast majority of my shares.

[As a matter of fact, I have been averaged up all the way from the jump out the teens to most recently at around 0.63, 0.61, 0.59]

[I believe a big surprise is in the making, a big positive surprise to be exact]